Package 60687-637-65

{"route": ["SUBLINGUAL"], "spl_id": "202259e2-8dae-1a15-e063-6394a90a1020", "openfda": {"unii": ["5Q187997EE", "56W8MW3EN1"], "rxcui": ["351266", "351267"], "spl_set_id": ["b05b0087-c0ef-40be-9bf3-3933f6cd3492"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "50 BLISTER PACK in 1 CARTON (60687-637-65)  / 1 TABLET in 1 BLISTER PACK (60687-637-11)", "package_ndc": "60687-637-65", "marketing_start_date": "20220314"}], "brand_name": "Buprenorphine and Naloxone", "product_id": "60687-637_202259e2-8dae-1a15-e063-6394a90a1020", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "60687-637", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine and Naloxone", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": "2 mg/1"}], "application_number": "ANDA205601", "marketing_category": "ANDA", "marketing_start_date": "20220314", "listing_expiration_date": "20261231"}